These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8410509)

  • 1. The enigma of persistent hyperinsulinemic hypoglycemia of infancy.
    Daneman D; Ehrlich RM
    J Pediatr; 1993 Oct; 123(4):573-5. PubMed ID: 8410509
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy.
    Glaser B; Hirsch HJ; Landau H
    J Pediatr; 1993 Oct; 123(4):644-50. PubMed ID: 8410523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy.
    Apak RA; Yurdakök M; Oran O; Senocak ME; Cağlar M
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():143-5. PubMed ID: 9642652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal growth after administration of octreotide: report on a case of persistent hyperinsulinemic hypoglycemia of infancy treated by continuous subcutaneous injection of octreotide.
    Kuno T; Fujita I; Ohta M; Kanemitsu H; Miyazaki S; Miyamoto S
    Endocr J; 1999 Mar; 46 Suppl():S47-9. PubMed ID: 12054118
    [No Abstract]   [Full Text] [Related]  

  • 5. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism.
    Thornton PS; Alter CA; Katz LE; Baker L; Stanley CA
    J Pediatr; 1993 Oct; 123(4):637-43. PubMed ID: 8410522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
    DeClue TJ; Malone JI; Bercu BB
    J Pediatr; 1990 May; 116(5):747-50. PubMed ID: 2184212
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
    Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
    J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
    Hussain K; Aynsley-Green A; Stanley CA
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():163-7. PubMed ID: 16456495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism in infancy.
    Low LC; Yu EC; Chow OK; Yeung CY; Young RT
    Aust Paediatr J; 1989 Jun; 25(3):174-7. PubMed ID: 2764841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogue SMS 201-995 in the short-term management of neonatal hyperinsulinism due to nesidioblastosis.
    Sullivan MJ; Taylor BJ; Broadbent RS; Yun K; Lovell-Smith M; Donald RA
    Aust Paediatr J; 1988 Dec; 24(6):375-8. PubMed ID: 3071997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.
    Hawdon JM; Ward Platt MP; Lamb WH; Aynsley-Green A
    Arch Dis Child; 1991 Mar; 66(3):341-3. PubMed ID: 2025013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent neonatal hyperinsulinemic hypoglycemia in two siblings successfully treated with diazoxide.
    Wüthrich C; Schubiger G; Zuppinger K
    Helv Paediatr Acta; 1986 Dec; 41(5):455-9. PubMed ID: 3818333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term diazoxide therapy in recurrent leucine-sensitive hypoglycemia (author's transl)].
    Maertens P; de Geeter B; Kurtz F; Messer J; Raber A; Willard D
    Ann Pediatr (Paris); 1980 Dec; 27(10):677-81. PubMed ID: 7212555
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.
    Darendeliler F; Bundak R; Bas F; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 1997; 10(1):79-81. PubMed ID: 9364348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent hyperinsulinemic hypoglycemia of infancy: long-term results.
    Dacou-Voutetakis C; Psychou F; Maniati-Christidis M
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():131-41. PubMed ID: 9642651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism: exclusive human milk and breastfeeding.
    Edwards TM; Spatz DL
    Adv Neonatal Care; 2014 Aug; 14(4):262-6; quiz 267-8. PubMed ID: 25000103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persistent hyperinsulinemic hypoglycemia of infancy (PHHI)].
    Yamada Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():900-3. PubMed ID: 9434584
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent hyperinsulinaemic hypoglycaemia of infancy: case report.
    Semiz S; Bircan I; Akçurin S; Mihçi E; Melikoglu M; Karagüzel G; Kiliçaslan B; Karpuzoğlu G
    East Afr Med J; 2002 Oct; 79(10):554-6. PubMed ID: 12635764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
    Clark W; O'Donovan D
    Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.